Patents Assigned to Nextran Inc.
  • Publication number: 20030224350
    Abstract: Porcine nucleic acid sequences flanking potentially infectious porcine endogenous retroviral (PERV) insertion sites have been identified and isolated. The unique flanking sequences include porcine nucleic acid sequences that flank the 3′ end and porcine nucleic acid sequences that flank the 5′ end of PERV insertion sites. The present invention provides compositions and methods for detecting presence of PERV in a sample, particularly those with infectious potential. In addition, the invention relates to breeding of pigs or selection of porcine tissue that is free of infectious PERV for use as a xenotransplant tissue.
    Type: Application
    Filed: March 28, 2002
    Publication date: December 4, 2003
    Applicant: Nextran, Inc.
    Inventors: Cinqi Cui, Lisa E. Diamond, John S. Logan
  • Patent number: 6166288
    Abstract: A method of xenotransplanting organs, tissues, cells or non-viable components which reduces or prevents antibody-mediated rejections, including hyperacute rejection, is provided wherein transgenic animals are produced that express at least one enzyme which masks or reduces the level of the antigenic Gal.alpha.(1,3)Gal or gal epitope, and at least one complement inhibitor such as CD59, DAF and/or MCP. The transgenic animals which express both a gal epitope-reducing enzyme and a complement inhibitor will have masked or reduced levels of the gal epitope and will be much less likely to produce an antibody-mediated rejection following transplantation, and the expression of the complement inhibitor will also suppress complement activation and reduce even further a severe immune reaction following the transplantation of donor organs, tissue, cells or non-viable components from the transgenic animals so produced.
    Type: Grant
    Filed: July 3, 1996
    Date of Patent: December 26, 2000
    Assignee: Nextran Inc.
    Inventors: Lisa E. Diamond, John S. Logan, Geurard W. Byrne, Ajay Sharma